Erik Lundin
Oerebro, T, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Metastasis-directed SBRT for oligometastatic hormone sensitive prostate cancer (METRO): protocol for a prospective randomised phase III trial, NCT04983095.
Journal: BMC cancer
Published: January 21, 2026
Open or closed: Experience of head and neck radiotherapy masks - A mixed-methods study.
Journal: Journal of medical radiation sciences
Published: November 29, 2023
Radiotherapy as Elective Treatment of the Node-negative Neck in Oral Squamous Cell Cancer.
Journal: Anticancer research
Published: April 27, 2021
High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center.
Journal: Journal of contemporary brachytherapy
Published: October 07, 2020
Validation of a Clinical Cancer Register at the Head and Neck Oncology Center in Örebro.
Journal: Anticancer research
Published: November 16, 2018
Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 10, 2018
Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: May 05, 2015
Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 29, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026